Home › Compare › MAXQF vs MRK

MAXQF vs MRK: Dividend Comparison 2026

MAXQF yields 438.79% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MAXQF wins by $22708.83M in total portfolio value
10 years
MAXQF
MAXQF
● Live price
438.79%
Share price
$0.46
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22708.86M
Annual income
$15,679,518,541.24
Full MAXQF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — MAXQF vs MRK

📍 MAXQF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMAXQFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MAXQF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MAXQF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MAXQF
Annual income on $10K today (after 15% tax)
$37,297.06/yr
After 10yr DRIP, annual income (after tax)
$13,327,590,760.05/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MAXQF beats the other by $13,327,589,952.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MAXQF + MRK for your $10,000?

MAXQF: 50%MRK: 50%
100% MRK50/50100% MAXQF
Portfolio after 10yr
$11354.45M
Annual income
$7,839,759,745.77/yr
Blended yield
69.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MAXQF
No analyst data
Altman Z
2.8
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MAXQF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMAXQFMRK
Forward yield438.79% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$22708.86M ✓$30.7K
Annual income after 10y$15,679,518,541.24 ✓$950.29
Total dividends collected$22077.80M ✓$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MAXQF vs MRK ($10,000, DRIP)

YearMAXQF PortfolioMAXQF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$54,579$43,878.89$11,192$351.54+$43.4K → MAXQF
2$282,218$223,818.83$12,524$392.70+$269.7K → MAXQF
3$1,383,590$1,081,616.28$14,015$438.65+$1.37M → MAXQF
4$6,436,217$4,955,776.33$15,682$489.96+$6.42M → MAXQF
5$28,431,989$21,545,236.75$17,547$547.23+$28.41M → MAXQF
6$119,371,836$88,949,607.26$19,632$611.16+$119.35M → MAXQF
7$476,751,535$349,023,670.94$21,963$682.53+$476.73M → MAXQF
8$1,812,874,891$1,302,750,748.56$24,571$762.18+$1812.85M → MAXQF
9$6,569,480,795$4,629,704,660.99$27,486$851.08+$6569.45M → MAXQF
10$22,708,862,992$15,679,518,541.24$30,745$950.29+$22708.83M → MAXQF

MAXQF vs MRK: Complete Analysis 2026

MAXQF — Stock

Maritime Launch Services Inc. operates as a commercial space company in Nova Scotia. It is developing Spaceport Nova Scotia, a launch site that provides satellite delivery services, which enables clients in the commercial space transportation industry to place their satellites into low-earth orbit. The company is headquartered in Halifax, Canada.

Full MAXQF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this MAXQF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MAXQF vs SCHDMAXQF vs JEPIMAXQF vs OMAXQF vs KOMAXQF vs MAINMAXQF vs JNJMAXQF vs ABBVMAXQF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.